𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Revisiting the specificity of the MHC class II transactivator CIITA in vivo

✍ Scribed by Luc A. Otten; Salomé LeibundGut-Landmann; Joachim Huarte; Isabelle C. Kos-Braun; Christine Lavanchy; Emmanuèle Barras; Bettina Borisch; Viktor Steimle; Hans Acha-Orbea; Walter Reith

Publisher
John Wiley and Sons
Year
2006
Tongue
English
Weight
442 KB
Volume
36
Category
Article
ISSN
0014-2980

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Quantitative control of MHC class II exp
Quantitative control of MHC class II expression by the transactivator CIITA
✍ Luc Alain Otten; Viktor Steimle; Séverine Bontron; Bernard Mach 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 125 KB 👁 2 views

Activation of T lymphocytes is quantitatively controlled by the level of expression of MHC class II molecules. Both constitutive and inducible expression of MHC class II genes is regulated by the transactivator CIITA, which is itself tightly regulated. Since the level of MHC class II molecules expre

Regulation of MHC class II expression in
Regulation of MHC class II expression in glioma cells by class II transactivator (CIITA)
✍ Yukio Takamura; Hideyuki Ikeda; Takayuki Kanaseki; Minoru Toyota; Takashi Tokino 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 877 KB

## Abstract We first classified 12 malignant glioma cell lines into three different groups (types 1–3) with respect to major histocompatibility complex (MHC) class II expression and analyzed each group based on the different expression status of the class II transactivator (CIITA) gene. Glioma type

Regulation of the expression of MHC clas
Regulation of the expression of MHC class I and II by class II transactivator (CIITA) in hematopoietic cells
✍ Aichun Liu; Masuhiro Takahashi; Ken Toba; Zhiyin Zheng; Shigeo Hashimoto; Kohji 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 437 KB 👁 2 views

In order to develop an effective immunotherapy for hematological malignancies, we investigated the applicability of class II transactivator (CIITA), which had been demonstrated to regulate the expression of MHC class II (MHC-II) by assembling the transcription factors of MHC-II molecules, for immuno